Home › Companies › EDITAS MEDICINE INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and EDITAS MEDICINE INC.’s Form 8-K, filed May 31, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of May 30, 2024: 5 items on EDITAS MEDICINE INC.’s Form 8-K, filed May 31, 2024: 2 approved · 3 passed (calculated).
Significant dissent: 3 directors (21.2%, 21.2%, 20.9% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2023-2024 2024-2025 2025-2026
Activist investors: Ra Capital Management, L.P. (13F, 5.8%, as of September 30, 2026)
Explore EDITAS MEDICINE INC. in the interactive database Compare manager voting policies
These tallies are EDITAS MEDICINE INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 31, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Meeta Chatterjee, Ph.D. | 32,769,825 | -- | -- | 8,815,678 | 17,765,319 | 79% | Passed (calculated) | — |
| Elect Director: Andrew Hirsch | 32,759,650 | -- | -- | 8,825,853 | 17,765,319 | 79% | Passed (calculated) | — |
| Elect Director: Gilmore O'Neill, M.B. | 32,909,172 | -- | -- | 8,676,331 | 17,765,319 | 79% | Passed (calculated) | — |
| 2. The compensation paid to its named executive officers | 38,609,828 | 2,769,887 | 205,788 | -- | 17,765,319 | 93% | Approved | — |
| 3. The selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the current fiscal year | 57,952,408 | 362,117 | 1,036,297 | -- | 0 | 99.4% | Approved | — |
Source: EDITAS MEDICINE INC., Form 8-K, filed with the SEC on May 31, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
287 asset managers disclosed a vote on at least one EDITAS MEDICINE INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
79% Majority: yes · of votes cast
Description as filed by funds: Election of three Class II Directors, each to serve until the 2027 Annual Meeting of Stockholders: Andrew Hirsch
EDITAS MEDICINE INC.’s own tally for this item (“Elect Director: Andrew Hirsch”): 32,759,650 for, 8,825,853 withheld, per its Form 8-K filed May 31, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 79% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 58 asset managers below reported 19,301,339 for, 3,544,425 withheld, 83,576 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 8,440,666 | 0 | 0 | 0 | For |
| State Street | 5,754,847 | 0 | 0 | 84,150 | For |
| BlackRock | 1,799,371 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 1,668,990 | Withhold |
| TIAA | 1,003,672 | 0 | 0 | 0 | For |
| Charles Schwab | 856,095 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 633,402 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 520,168 | Withhold |
| Fidelity | 293,368 | 0 | 0 | 0 | For |
| Equitable | 124,737 | 0 | 0 | 81,300 | Mixed |
| Global X | 185,398 | 0 | 0 | 0 | For |
| SEI | 158,118 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 145,221 | Withhold |
| Neuberger Berman | 137,826 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 125,434 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 111,152 | Withhold |
| Jackson National | 71,043 | 0 | 20,635 | 0 | Mixed |
| Northern Trust | 79,337 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 0 | 0 | 78,471 | Withhold |
| Lincoln Financial | 70,938 | 0 | 0 | 3,993 | Mixed |
| Bridge Builder Trust | 33,545 | 0 | 23,960 | 0 | Mixed |
| AIG/SunAmerica | 0 | 0 | 0 | 40,870 | Withhold |
| Pacific Life | 32,318 | 0 | 0 | 0 | For |
| Listed Funds Trust | 0 | 0 | 0 | 31,670 | Withhold |
| Prudential/PGIM | 31,295 | 0 | 0 | 0 | For |
Showing the 25 largest of 58 asset managers. All 58 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
79% Majority: yes · of votes cast
Description as filed by funds: Election of three Class II Directors, each to serve until the 2027 Annual Meeting of Stockholders: Gilmore O'Neill, M.B.
EDITAS MEDICINE INC.’s own tally for this item (“Elect Director: Gilmore O'Neill, M.B.”): 32,909,172 for, 8,676,331 withheld, per its Form 8-K filed May 31, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 79% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 58 asset managers below reported 19,382,639 for, 3,463,125 withheld, 83,576 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 8,440,666 | 0 | 0 | 0 | For |
| State Street | 5,754,847 | 0 | 0 | 84,150 | For |
| BlackRock | 1,799,371 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 1,668,990 | Withhold |
| TIAA | 1,003,672 | 0 | 0 | 0 | For |
| Charles Schwab | 856,095 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 633,402 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 520,168 | Withhold |
| Fidelity | 293,368 | 0 | 0 | 0 | For |
| Equitable | 206,037 | 0 | 0 | 0 | For |
| Global X | 185,398 | 0 | 0 | 0 | For |
| SEI | 158,118 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 145,221 | Withhold |
| Neuberger Berman | 137,826 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 125,434 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 111,152 | Withhold |
| Jackson National | 71,043 | 0 | 20,635 | 0 | Mixed |
| Northern Trust | 79,337 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 0 | 0 | 78,471 | Withhold |
| Lincoln Financial | 70,938 | 0 | 0 | 3,993 | Mixed |
| Bridge Builder Trust | 33,545 | 0 | 23,960 | 0 | Mixed |
| AIG/SunAmerica | 0 | 0 | 0 | 40,870 | Withhold |
| Pacific Life | 32,318 | 0 | 0 | 0 | For |
| Listed Funds Trust | 0 | 0 | 0 | 31,670 | Withhold |
| Prudential/PGIM | 31,295 | 0 | 0 | 0 | For |
Showing the 25 largest of 58 asset managers. All 58 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
79% Majority: yes · of votes cast
Description as filed by funds: Election of three Class II Directors, each to serve until the 2027 Annual Meeting of Stockholders: Meeta Chatterjee, Ph.D.
EDITAS MEDICINE INC.’s own tally for this item (“Elect Director: Meeta Chatterjee, Ph.D.”): 32,769,825 for, 8,815,678 withheld, per its Form 8-K filed May 31, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 79% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 58 asset managers below reported 19,301,339 for, 3,544,425 withheld, 83,576 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 8,440,666 | 0 | 0 | 0 | For |
| State Street | 5,754,847 | 0 | 0 | 84,150 | For |
| BlackRock | 1,799,371 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 1,668,990 | Withhold |
| TIAA | 1,003,672 | 0 | 0 | 0 | For |
| Charles Schwab | 856,095 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 633,402 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 520,168 | Withhold |
| Fidelity | 293,368 | 0 | 0 | 0 | For |
| Equitable | 124,737 | 0 | 0 | 81,300 | Mixed |
| Global X | 185,398 | 0 | 0 | 0 | For |
| SEI | 158,118 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 145,221 | Withhold |
| Neuberger Berman | 137,826 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 125,434 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 111,152 | Withhold |
| Jackson National | 71,043 | 0 | 20,635 | 0 | Mixed |
| Northern Trust | 79,337 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 0 | 0 | 78,471 | Withhold |
| Lincoln Financial | 70,938 | 0 | 0 | 3,993 | Mixed |
| Bridge Builder Trust | 33,545 | 0 | 23,960 | 0 | Mixed |
| AIG/SunAmerica | 0 | 0 | 0 | 40,870 | Withhold |
| Pacific Life | 32,318 | 0 | 0 | 0 | For |
| Listed Funds Trust | 0 | 0 | 0 | 31,670 | Withhold |
| Prudential/PGIM | 31,295 | 0 | 0 | 0 | For |
Showing the 25 largest of 58 asset managers. All 58 are in the interactive database (link above).
Combines 17 wordings of this item as funds reported it.
93% Approved · of votes cast
Prior year: 89.8% for (June 1, 2023 meeting) ▲ 3.5 pts
Description as filed by funds: To approve, on an advisory basis, the compensation paid to the Company's named executive officers.
EDITAS MEDICINE INC.’s own tally for this item (“2. The compensation paid to its named executive officers”): 38,609,828 for, 2,769,887 against — passed, per its Form 8-K filed May 31, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved, on an advisory basis, the compensation paid to its named executive officers.”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 8,440,666 | 0 | 0 | 0 | For |
| State Street | 5,838,997 | 0 | 0 | 0 | For |
| BlackRock | 1,799,371 | 0 | 0 | 0 | For |
| Dimensional | 1,668,990 | 0 | 0 | 0 | For |
| TIAA | 1,003,672 | 0 | 0 | 0 | For |
| Charles Schwab | 856,095 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 633,402 | 0 | 0 | 0 | For |
| Goldman Sachs | 520,168 | 0 | 0 | 0 | For |
| Fidelity | 293,368 | 0 | 0 | 0 | For |
| Equitable | 206,037 | 0 | 0 | 0 | For |
| Global X | 185,398 | 0 | 0 | 0 | For |
| SEI | 158,118 | 0 | 0 | 0 | For |
| ProShares | 145,221 | 0 | 0 | 0 | For |
| Neuberger Berman | 137,826 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 125,434 | 0 | 0 | 0 | For |
| American Century | 111,152 | 0 | 0 | 0 | For |
| Jackson National | 91,678 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 0 | 89,803 | 0 | 0 | Against |
| Northern Trust | 79,337 | 0 | 0 | 0 | For |
| Victory Capital | 78,471 | 0 | 0 | 0 | For |
| Lincoln Financial | 74,931 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 57,505 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 40,870 | 0 | 0 | 0 | For |
| Pacific Life | 32,318 | 0 | 0 | 0 | For |
| Listed Funds Trust | 31,670 | 0 | 0 | 0 | For |
Fund voting reports, all 60 managers: 22,902,037 for, 98,048 against, 20,268 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 7,371,900 | 0 | 0 | 0 | For |
| BlackRock | 2,505,728 | 0 | 0 | 0 | For |
| Deep Track Capital, LP | 1,920,429 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 1,126,151 | 0 | 0 | 0 | For |
| Nuveen | 1,013,880 | 0 | 0 | 0 | For |
| JPMorgan | 987,502 | 0 | 0 | 0 | For |
| Woodline Partners LP | 895,000 | 0 | 0 | 0 | For |
| Charles Schwab | 856,095 | 0 | 0 | 0 | For |
| UBS | 3,287 | 700,266 | 0 | 0 | Against |
| MARSHALL WACE, LLP | 0 | 693,855 | 0 | 0 | Against |
| Rafferty Asset Management, LLC | 633,402 | 0 | 0 | 0 | For |
| DE Shaw | 476,805 | 0 | 0 | 0 | For |
| Northern Trust | 428,940 | 2,878 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 343,763 | 0 | 0 | 0 | For |
| Dimensional | 306,871 | 0 | 0 | 0 | For |
| Neuberger Berman | 275,452 | 0 | 0 | 0 | For |
| STIFEL NICOLAUS & CO INC \MO\ | 247,121 | 0 | 0 | 0 | For |
| Two Sigma | 204,233 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 162,341 | 0 | 0 | 0 | For |
| SEI | 161,892 | 0 | 0 | 0 | For |
| Goldman Sachs | 153,165 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 151,912 | 0 | 0 | 0 | For |
| Knott David M Jr | 140,000 | 0 | 0 | 0 | For |
| Citadel | 130,523 | 0 | 0 | 0 | For |
| Connor, Clark & Lunn Investment Management Ltd. | 119,560 | 0 | 0 | 0 | For |
Institutional-manager reports, all 247 managers: 22,251,338 for, 1,592,540 against, 270 abstained, 19,771 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.4% Approved · of votes cast
Prior year: 99.2% for (June 1, 2023 meeting) ▲ 0.2 pts
Description as filed by funds: TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2024.
EDITAS MEDICINE INC.’s own tally for this item (“3. The selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the current fiscal year”): 57,952,408 for, 362,117 against — passed, per its Form 8-K filed May 31, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders ratified the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the current fiscal year.”
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 61 asset managers below reported 22,990,189 for, 9,916 against, 20,268 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 8,440,666 | 0 | 0 | 0 | For |
| State Street | 5,829,081 | 9,916 | 0 | 0 | For |
| BlackRock | 1,799,371 | 0 | 0 | 0 | For |
| Dimensional | 1,668,990 | 0 | 0 | 0 | For |
| TIAA | 1,003,672 | 0 | 0 | 0 | For |
| Charles Schwab | 856,095 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 633,402 | 0 | 0 | 0 | For |
| Goldman Sachs | 520,168 | 0 | 0 | 0 | For |
| Fidelity | 293,368 | 0 | 0 | 0 | For |
| Equitable | 206,037 | 0 | 0 | 0 | For |
| Global X | 185,398 | 0 | 0 | 0 | For |
| SEI | 158,118 | 0 | 0 | 0 | For |
| ProShares | 145,221 | 0 | 0 | 0 | For |
| Neuberger Berman | 137,826 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 125,434 | 0 | 0 | 0 | For |
| American Century | 111,152 | 0 | 0 | 0 | For |
| Jackson National | 91,678 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 89,803 | 0 | 0 | 0 | For |
| Northern Trust | 79,337 | 0 | 0 | 0 | For |
| Victory Capital | 78,471 | 0 | 0 | 0 | For |
| Lincoln Financial | 74,931 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 57,505 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 40,870 | 0 | 0 | 0 | For |
| Pacific Life | 32,318 | 0 | 0 | 0 | For |
| Listed Funds Trust | 31,670 | 0 | 0 | 0 | For |
Showing the 25 largest of 61 asset managers. All 61 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 82,234,951 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 10.26% |
| 2 | State Street | 7.10% |
| 3 | BlackRock | 2.19% |
| 4 | Dimensional | 2.03% |
| 5 | TIAA | 1.22% |
| 6 | Charles Schwab | 1.04% |
| 7 | Direxion Shares ETF Trust | 0.77% |
| 8 | Goldman Sachs | 0.63% |
| 9 | Fidelity | 0.36% |
| 10 | Equitable | 0.25% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | State Street | 8.96% |
| 2 | BlackRock | 3.05% |
| 3 | Deep Track Capital, LP | 2.34% |
| 4 | PICTET ASSET MANAGEMENT SA | 1.37% |
| 5 | Nuveen | 1.23% |
| 6 | JPMorgan | 1.20% |
| 7 | Woodline Partners LP | 1.09% |
| 8 | Charles Schwab | 1.06% |
| 9 | UBS | 0.86% |
| 10 | MARSHALL WACE, LLP | 0.84% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| State Street | 8,760,151 | 10.65% | Form 13F, quarter ended March 31, 2024 |
| BlackRock | 8,019,891 | 9.75% | Form 13F, quarter ended March 31, 2024 |
| Vanguard Group | 6,965,618 | 8.47% | Form 13F, quarter ended March 31, 2024 |
| Deep Track Capital, LP | 5,473,086 | 6.66% | Proxy statement (DEF 14A), proxy filed April 16, 2024 |
| Dimensional Fund Advisors | 2,607,765 | 3.17% | Form 13F, quarter ended March 31, 2024 |
| Millennium Management | 2,236,617 | 2.72% | Form 13F, quarter ended March 31, 2024 |
| Geode Capital | 1,944,763 | 2.36% | Form 13F, quarter ended March 31, 2024 |
| Two Sigma | 1,387,982 | 1.69% | Form 13F, quarter ended March 31, 2024 |
| D.E. Shaw | 1,089,240 | 1.32% | Form 13F, quarter ended March 31, 2024 |
| Morgan Stanley | 1,087,907 | 1.32% | Form 13F, quarter ended March 31, 2024 |
Percentages above are of 82,234,951 shares outstanding, as reported by EDITAS MEDICINE INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At EDITAS MEDICINE INC.'s shareholder meeting held May 30, 2024, in the 2023-2024 proxy season, 287 asset managers reported votes on at least one of its 5 ballot items in their SEC Form N-PX filings, covering 1,281 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation paid to the Company's named executive… — EDITAS MEDICINE INC.'s filing reports the proposal as approved, with 93% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: EDITAS MEDICINE INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 31, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from EDITAS MEDICINE INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
EDITAS MEDICINE INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Proxy Votes Now, “EDITAS MEDICINE (EDIT) 2024 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/editas-medicine-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.